Department of Biomedical and Pharmaceutical Sciences, Center for Environmental Health Sciences, The University of Montana, Missoula, MT 59812-1552, USA.
Nanotoxicology. 2013 Sep;7(6):1070-81. doi: 10.3109/17435390.2012.702230. Epub 2012 Jun 29.
Allergic asthma is a chronic inflammatory disorder of the airway associated with bronchial obstruction, airway hyper-reactivity (AHR), and mucus production. The epithelium may direct and propagate asthmatic-like responses. Central to this theory is the observation that viruses, air pollution, and allergens promote epithelial damage and trigger the generation of IL-25, IL-33, and TSLP via innate pathways such as TLRs and purinergic receptors. Similarly, engineered nanomaterials promote a Th2-associated pathophysiology. In this study, we tested the hypothesis that instillation of multi-walled carbon nanotubes (MWCNT) impair pulmonary function in C57Bl/6 mice due to the development of IL-33-dependent Th2-associated inflammation. MWCNT exposure resulted in elevated levels of IL-33 in the lavage fluid (likely originating from airway epithelial cells), enhanced AHR, eosinophil recruitment, and production of Th2-associated cytokines and chemokines. Moreover, these events were dependent on IL-13 signaling and the IL-33/ST2 axis, but independent of T and B cells. Finally, MWCNT exposure resulted in the recruitment of innate lymphoid cells. Collectively, our data suggest that MWCNT induce epithelial damage that results in release of IL-33, which in turn promotes innate lymphoid cell recruitment and the development of IL-13-dependent inflammatory response.
过敏性哮喘是一种气道慢性炎症性疾病,与支气管阻塞、气道高反应性(AHR)和黏液产生有关。上皮细胞可能会指导和传播类似哮喘的反应。这一理论的核心是观察到病毒、空气污染和过敏原通过 TLR 和嘌呤能受体等先天途径促进上皮细胞损伤,并触发 IL-25、IL-33 和 TSLP 的产生。同样,工程纳米材料也促进了 Th2 相关的病理生理学。在这项研究中,我们假设多壁碳纳米管(MWCNT)的注入会由于 IL-33 依赖性 Th2 相关炎症的发展而损害 C57Bl/6 小鼠的肺功能。MWCNT 暴露导致灌洗液中 IL-33 水平升高(可能来源于气道上皮细胞),增强 AHR、嗜酸性粒细胞募集以及 Th2 相关细胞因子和趋化因子的产生。此外,这些事件依赖于 IL-13 信号和 IL-33/ST2 轴,但不依赖于 T 和 B 细胞。最后,MWCNT 暴露导致固有淋巴细胞的募集。总之,我们的数据表明,MWCNT 诱导上皮细胞损伤,导致 IL-33 的释放,进而促进固有淋巴细胞的募集和 IL-13 依赖性炎症反应的发展。